Brief: Evaxion Announces Phase 2 Clinical Trial Update

Evaxion A/S

17/04/2024 13:19

April 17 (Reuters) - Evaxion Biotech A/S  EVAX.O :
    * EVAXION ANNOUNCES PHASE 2 CLINICAL TRIAL UPDATE: FIRST
PATIENT
COMPLETED DOSING WITH PERSONALIZED CANCER VACCINE EVX-01
    * EVAXION BIOTECH A/S - TRIAL ON TRACK FOR ONE-YEAR CLINICAL
EFFICACY READOUT IN Q3 2024
    * EVAXION BIOTECH A/S - FAVORABLE SAFETY PROFILE CONFIRMED

Source text for Eikon:  ID:nGNXbfHSJY 
Further company coverage:  EVAX.O 

 ((Reuters.Briefs@thomsonreuters.com;))